NEW YORK (Reuters) - Just weeks after prosecutors accused Forest Laboratories Inc of illegally marketing its anti-depressants Celexa and Lexapro to children and paying pediatricians kickbacks, U.S.
Forest Pharmaceuticals Inc. and Forest Laboratories Inc. are facing multiple proposed class actions in which the plaintiffs allege antidepressants Celexa and Lexapro were unlawfully marketed to treat ...
WASHINGTON, Feb 25 (Reuters) - The United States accused Forest Laboratories Inc of inappropriately marketing the drugs Celexa and Lexapro for children and paying kickbacks like spa visits to ...
Harvard Pilgrim Health Care Institute (HPHCI) researchers analyzed the weights of more than 183,000 adult antidepressant users six months, a year and two years after they started taking the drugs.
THURSDAY, Aug. 15 (HealthScoutNews) -- The U.S. Food and Drug Administration (FDA) today approved the drug Lexapro (escitalopram) for the treatment for major depression. Lexapro resulted from a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results